Provention Bio, Inc. PRVB
Set alert
24.98 +24.98 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 2.38B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -192.15
- Beta
- 2.46
- Short ratio
- 1.53
- Inst. own
- 53.26%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 4, 2023
- 50-d avg
- 19.10
- 200-d avg
- 10.15
- 1y target
- 23.50
YTD chart
Events in this range
- Feb 15, 2023Rating: HC Wainwright & Co. · — → Buy
- Mar 13, 2023Rating: Chardan Capital · — → Buy
- Mar 14, 2023Downgrade: Jefferies · Buy → Hold
- Mar 14, 2023Downgrade: SMBC Nikko · Outperform → Neutral
- Mar 15, 2023Downgrade: HC Wainwright & Co. · Buy → Neutral
Signals (20)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Mar 31, 2023 | 3 years ago |
| SMA: Bullish | Mar 13, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 13, 2023 | 3 years ago |
| RSI: Overbought | Mar 13, 2023 | 3 years ago |
| RSI: Oversold | Mar 10, 2023 | 3 years ago |
| RSI: Oversold | Mar 8, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 22, 2023 | 3 years ago |
| SMA: Bearish | Feb 21, 2023 | 3 years ago |
| SMA: Bullish | Feb 9, 2023 | 3 years ago |
| SMA: Bearish | Feb 8, 2023 | 3 years ago |
| SMA: Bullish | Feb 7, 2023 | 3 years ago |
| SMA: Bearish | Feb 6, 2023 | 3 years ago |
| MACD: Buy Signal | Feb 6, 2023 | 3 years ago |
| SMA: Bullish | Feb 3, 2023 | 3 years ago |
| SMA: Bearish | Jan 18, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 18, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 17, 2023 | 3 years ago |
| SMA: Bullish | Jan 10, 2023 | 3 years ago |
| SMA: Bearish | Jan 9, 2023 | 3 years ago |
| MACD: Sell Signal | Jan 4, 2023 | 3 years ago |
Ownership
Held by insiders 4.62%
Held by institutions 53.26%
Float held by institutions 55.84%
Institutions 202
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Sessa Capital IM, L.P. | 15.70% | 14,879,023 | 371.68M | Dec 30, 2022 |
| Blackrock Inc. | 5.89% | 5,579,604 | 139.38M | Dec 30, 2022 |
| Vanguard Group, Inc. (The) | 4.37% | 4,142,744 | 103.49M | Dec 30, 2022 |
| Adage Capital Partners GP L.L.C. | 2.66% | 2,519,257 | 62.93M | Dec 30, 2022 |
| State Street Corporation | 1.64% | 1,558,238 | 38.92M | Dec 30, 2022 |
| Geode Capital Management, LLC | 1.39% | 1,322,189 | 33.03M | Dec 30, 2022 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.69% | 2,553,871 | 63.80M | Dec 30, 2022 |
| iShares Russell 2000 ETF | 1.46% | 1,380,809 | 34.49M | Feb 27, 2023 |
| Vanguard Extended Market Index Fund | 1.11% | 1,052,768 | 26.30M | Dec 30, 2022 |
| iShares NASDAQ Biotechnology ETF | 0.67% | 635,394 | 15.87M | Feb 27, 2023 |
| Fidelity Small Cap Index Fund | 0.55% | 521,048 | 13.02M | Jan 30, 2023 |
| Principal Capital Appreciation Fund | 0.49% | 460,658 | 11.51M | Jan 30, 2023 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BLUESTONE JEFFREY PH.D. | Director | Conversion of Exercise of derivative security | Apr 9, 2020 | 0 |
| CATLIN AVERY W | Director | Stock Gift | Apr 12, 2023 | 20,000 |
| DIGIANDOMENICO ANTHONY | Director | Purchase | Sep 29, 2019 | 178,712 |
| DRECHSLER ANDREW T | Chief Financial Officer | Purchase | Sep 1, 2020 | 20,000 |
| HOITT JASON | Officer | Sale | Feb 9, 2023 | 0 |
| LEON FRANCISCO | Officer | Stock Gift | Apr 12, 2023 | 146,000 |